Chronic dermatomycoses of the foot as risk factors for acute bacterial cellulitis of the leg: a case-control study.
about
Interventions for the prevention of recurrent erysipelas and cellulitisInterventions for cellulitis and erysipelasRecurrent erysipelas--risk factors and clinical presentation.Risk factors of lower limb cellulitis in a level-two healthcare facility in Cameroon: a case-control study.Psychosocial perception of adults with onychomycosis: a blinded, controlled comparison of 1,017 adult Hong Kong residents with or without onychomycosisOnychomycosis: modern diagnostic and treatment approaches.Bullous erysipelas: clinical presentation, staphylococcal involvement and methicillin resistance.Feasibility study to inform the design of a UK multi-centre randomised controlled trial of prophylactic antibiotics for the prevention of recurrent cellulitis of the legPatient considerations in the management of toe onychomycosis - role of efinaconazole.Molecular typing of Beta-hemolytic streptococci from two patients with lower-limb cellulitis: identical isolates from toe web and blood specimensRisk factors for nonpurulent leg cellulitis: a systematic review and meta-analysis.Prophylactic antibiotics for the prevention of cellulitis (erysipelas) of the leg: results of the UK Dermatology Clinical Trials Network's PATCH II trial.Oedema as a risk factor for multiple episodes of cellulitis/erysipelas of the lower leg: a series with community follow-up.Effective treatment for dermatophytoses of the foot: effect on restoration of depressed cell-mediated immunity.Common skin infections in travelers.Fungal foot infection, cellulitis and diabetes: a review.An update on treatment of onychomycosis.Therapeutic potential of TDT 067 (terbinafine in Transfersome): a carrier-based dosage form of terbinafine for onychomycosis.Interventions for the prevention of recurrent erysipelas and cellulitis.Risk factors for erysipelas of the leg in Tunisia: a multicenter case-control study.Predictors of failure of empiric outpatient antibiotic therapy in emergency department patients with uncomplicated cellulitis.Use of procalcitonin, C-reactive protein and white blood cell count to distinguish between lower limb erysipelas and deep vein thrombosis in the emergency department: A prospective observational study.Risk Factors for Chronic Intertrigo of the Lymphedema Leg in Southern India: A Case-Control Study.Preventing cellulitis: where next?Antifungal Effect of Non-Woven Textiles Containing Polyhexamethylene Biguanide with Sophorolipid: A Potential Method for Tinea Pedis Prevention.Tinea pedis presenting as asymmetric purpuric papules on the sole of the foot: a case report.Recurrent cellulitis: risk factors, etiology, pathogenesis and treatment.Intermittent versus continuous terbinafine in the treatment of toenail onychomycosis: a randomized, double-blind comparison.Ultrasound-Enhanced Drug Delivery for Treatment of Onychomycosis.Recurrent erysipelas: 47 cases.Erysipelas of the thigh and the gluteal region: retrospective multicenter analysis of a very rare entity in 39 patients.Benzathine penicillin G once-every-3-week prophylaxis for recurrent erysipelas a retrospective study of 132 patients.Seasonality of cellulitis: evidence from Google Trends.Mikroorganismen des Zehenzwischenraums - Bedeutung für das Beinerysipel.Fungi in the Wound Microbiome.Antifungal activity of L. (Sapindaceae) against occurs through molecular interaction with fungal Hsp90
P2860
Q24200758-DE0A9D7E-53D8-4AA0-9530-889E66060476Q24234864-A966E3CF-3840-41A6-9CA4-F79B7C32BE6FQ33662154-E66E690B-5D7D-40C7-9A75-A2FBCF19258BQ33791726-777C9FE7-1252-4AFC-B66A-2D11EDE21828Q33936313-E6E1D311-788A-4B5A-9420-05CCE10369BDQ34440038-3A8C34F0-96F0-4406-BD26-561A477519D7Q34471645-F4B46274-C125-4078-97CE-243033FBA8F5Q35633771-05E50652-A08B-4C1C-A587-C2FADFCDCE41Q35827685-8E43F515-CFFF-4A97-B818-47999229C21DQ36098667-A2B54C41-E74A-40E5-A1CF-C3F1DC2C914DQ36198455-1C5A71A8-1C36-4378-97BA-8FC386EA930FQ36387430-4DB689DB-4296-4C4D-AC13-7883BC9A3242Q36620753-7E2CFB51-2325-4710-BDBE-C1AB428D4A9DQ36917029-F57B55BA-FE63-4F08-B73A-314058EEB46EQ37230468-9042BCF4-CA65-4275-9960-15713AF08119Q37568091-92CD3641-7CE8-48EA-9810-1169B56379A9Q38006059-C6851263-09FE-4FB4-9DE3-525631D57376Q38033192-B7F1336E-BA22-4A54-9092-752D5F59AD6EQ38717950-8346463E-B1BE-4416-A988-081F7B528801Q39260583-79B6D07C-6488-448C-95EB-F38A88980A1AQ40206676-A812011B-1383-4833-9902-FAF282394D2BQ40931324-3CAD067D-2EDA-4E38-8356-0B39180C2E07Q41383461-DB540AF0-ED23-47CA-B402-63DD793FABADQ41591638-1ED581BD-3B04-4670-8753-B6D772FAD5B6Q41814473-BF05356C-AE77-49AD-86F4-BA64031A5370Q41850674-DC70BC2A-D7ED-41FA-80F6-6A6AD53D6549Q42208160-04F0A953-ADBD-4E58-B12A-B817594D6B79Q46934914-BA5CA21B-0CC6-4382-9D5C-0D8F2A6FA784Q47210309-C2F57656-D82A-4B29-80FF-6A7D1E5A9FCCQ52575897-FDAA0887-60A7-4566-A99B-BA95EBDAA70DQ52632727-014C4B95-4C4E-42E4-8A49-EBC4FA355FBDQ53613429-6CADBAC9-61DA-42D7-A041-BC94A4538237Q54210712-A5E427B9-8FA4-4A15-B0FF-6D51BA6AD82FQ54740038-1D022CC2-8C3A-48C2-A8E2-2229D1BE8E96Q55455094-DDF25626-EDA6-48A0-9EAE-77A184CC158CQ57922631-86EC4F07-6767-4D91-8A00-7A2440C760D5
P2860
Chronic dermatomycoses of the foot as risk factors for acute bacterial cellulitis of the leg: a case-control study.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Chronic dermatomycoses of the ...... the leg: a case-control study.
@en
Chronic dermatomycoses of the ...... the leg: a case-control study.
@nl
type
label
Chronic dermatomycoses of the ...... the leg: a case-control study.
@en
Chronic dermatomycoses of the ...... the leg: a case-control study.
@nl
prefLabel
Chronic dermatomycoses of the ...... the leg: a case-control study.
@en
Chronic dermatomycoses of the ...... the leg: a case-control study.
@nl
P2093
P2860
P356
P1433
P1476
Chronic dermatomycoses of the ...... the leg: a case-control study
@en
P2093
Hans-Christian Korting
Helmut Kerl
Jean-Claude Roujeau
P2860
P304
P356
10.1159/000080853
P577
2004-01-01T00:00:00Z